EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED

Andere Sprachen Extrawell Pharmaceutical Holdings Limited

Aktien

633407

BMG3285Q1134

858

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:12 17.06.2024			% 5 Tage	% 1. Jan.
0,036 ^HKD	0,00 %		-7,69 %	+5,88 %

07.06.	Extrawell Pharmaceutical Holdings Limited kündigt Änderungen im Vorstand und in den Ausschüssen an	CI
2023	Extrawell Pharmaceutical erleidet im ersten Halbjahr des Geschäftsjahres einen Verlust aufgrund von Marktwertverlusten	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Extrawell Pharmaceutical Holdings Limited Announces Board and Committee Changes	07.06.
Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses	30.11.
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	29.11.
Extrawell Pharmaceutical Holdings Forecasts Swing to Loss in Fiscal H1; Shares Fall 3%	13.11.
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2023	10.11.
Extrawell Pharmaceutical Amends Terms of Convertible Bonds by Innovative Pharmaceutical Biotech	12.07.23
Extrawell Pharmaceutical's Fiscal Year 2023 Attributable Profit Falls	30.06.23
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29.06.23
Extrawell Pharmaceutical Unit Completes Share Buyback Deal	20.06.23
Extrawell Pharmaceutical to Swing to Loss in FY23	16.06.23
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023	16.06.23
Extrawell Pharmaceutical Holdings Limited Appoints Guo Yi as an INED of the Company, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 April 2023	14.04.23
Extrawell Pharmaceutical Holdings Limited Announces Demise of Mr. Xue Jing Lun, Independent Non-Executive Director, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee	07.12.22
Extrawell Pharmaceutical's Profit for Six Months Through September Nearly Halves	30.11.22
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022	29.11.22
Extrawell Pharmaceutical Forecasts Decline in Fiscal H1 Profit	17.11.22
Extrawell Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022	17.11.22
Extrawell Pharmaceutical Holdings Limited Announces Management Changes	30.09.22
Extrawell Pharmaceutical Holdings Swings to Profitability in FY22	01.07.22
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2022	29.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Extrawell Pharmaceutical Holdings Limited

Aktien

633407

BMG3285Q1134

858

Andere Sprachen

Filter